Role of the Transcription Factor Yin Yang 1 and Its Selectively Identified Target Survivin in High-Grade B-Cells Non-Hodgkin Lymphomas: Potential Diagnostic and Therapeutic Targets.
Antineoplastic Combined Chemotherapy Protocols
/ pharmacology
Apoptosis
Biomarkers, Tumor
/ genetics
Cell Proliferation
Drug Resistance, Neoplasm
/ genetics
Gene Expression Regulation, Neoplastic
/ drug effects
Gene Silencing
Humans
Lymphoma, B-Cell
/ drug therapy
Survivin
/ genetics
Tumor Cells, Cultured
YY1 Transcription Factor
/ antagonists & inhibitors
B-cell non-Hodgkin lymphoma
BIRC5/survivin
Burkitt’s lymphoma
Yin Yang 1
apoptosis
chemotherapy
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
03 Sep 2020
03 Sep 2020
Historique:
received:
24
07
2020
revised:
21
08
2020
accepted:
02
09
2020
entrez:
9
9
2020
pubmed:
10
9
2020
medline:
30
3
2021
Statut:
epublish
Résumé
B-cell non-Hodgkin lymphomas (B-NHLs) are often characterized by the development of resistance to chemotherapeutic drugs and/or relapse. During drug-induced apoptosis, Yin Yang 1 (
Identifiants
pubmed: 32899428
pii: ijms21176446
doi: 10.3390/ijms21176446
pmc: PMC7504013
pii:
doi:
Substances chimiques
BIRC5 protein, human
0
Biomarkers, Tumor
0
Survivin
0
YY1 Transcription Factor
0
YY1 protein, human
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : University of Catania Linea di Intervento 2 2016-2018
ID : Linea di Intervento 2 2016-2018, Identification of cancer driver genes for novel diagnostic and therapeutic strategies
Références
Cell. 2018 Apr 5;173(2):371-385.e18
pubmed: 29625053
Crit Rev Oncog. 2011;16(3-4):163-97
pubmed: 22248053
Cell Death Dis. 2010 Jul 22;1:e57
pubmed: 21364662
Nature. 2012 Mar 04;483(7391):598-602
pubmed: 22388813
Nucleic Acids Res. 2018 Jan 4;46(D1):D794-D801
pubmed: 29126249
Genome Res. 2002 Jun;12(6):996-1006
pubmed: 12045153
PLoS One. 2014 May 14;9(5):e96901
pubmed: 24828675
Neoplasma. 2006;53(3):206-12
pubmed: 16652189
J Cancer. 2016 Jan 10;7(3):314-23
pubmed: 26918045
Haematologica. 2017 Jul;102(7):1139-1149
pubmed: 28554945
Mod Pathol. 2013 Jan;26 Suppl 1:S42-56
pubmed: 23154748
Theranostics. 2020 Mar 4;10(9):4183-4200
pubmed: 32226547
Crit Rev Oncog. 2017;22(1-2):23-36
pubmed: 29604934
Mol Cancer. 2015 Mar 07;14:56
pubmed: 25890196
Nat Genet. 2012 Dec;44(12):1316-20
pubmed: 23143595
Nucleic Acids Res. 2019 Jan 8;47(D1):D745-D751
pubmed: 30407521
Leukemia. 2010 Nov;24(11):1920-6
pubmed: 20882051
Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14484-9
pubmed: 20660740
Mol Cell Biol. 2006 May;26(9):3565-81
pubmed: 16611997
J Clin Invest. 2013 Jun;123(6):2395-407
pubmed: 23676502
J Clin Oncol. 2015 Apr 20;33(12):1379-88
pubmed: 25800755
PLoS One. 2016 May 11;11(5):e0155311
pubmed: 27167731
J Clin Oncol. 2017 May 20;35(15):1668-1677
pubmed: 28291392
Nucleic Acids Res. 2020 Jan 8;48(D1):D87-D92
pubmed: 31701148
Science. 1999 Feb 19;283(5405):1129-30
pubmed: 10075573
Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6062-7
pubmed: 15075390
Leukemia. 2004 Mar;18(3):616-23
pubmed: 14749704
Haematologica. 2011 Jul;96(7):996-1001
pubmed: 21546504
Cell Cycle. 2010 Feb 1;9(3):557-63
pubmed: 20081364
J Biol Chem. 2008 Feb 8;283(6):3289-96
pubmed: 18057009
Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6145-9
pubmed: 8327494
Oncotarget. 2019 Mar 15;10(22):2173-2188
pubmed: 31040909
Blood. 2014 Mar 13;123(11):1681-90
pubmed: 24037725
Cell Cycle. 2009 May 1;8(9):1367-72
pubmed: 19342874
Blood. 2011 Mar 31;117(13):3596-608
pubmed: 21245480
Neural Regen Res. 2019 Jul;14(7):1148-1151
pubmed: 30804239
Oncogene. 2005 Dec 8;24(55):8114-27
pubmed: 16103877
BMC Bioinformatics. 2012 Jun 18;13:134
pubmed: 22708584
N Engl J Med. 2006 Jun 8;354(23):2419-30
pubmed: 16760442
Cancer Causes Control. 2019 May;30(5):489-499
pubmed: 30895415
J Immunol. 2016 Mar 1;196(5):2195-204
pubmed: 26810226
PLoS One. 2013 Jul 10;8(7):e66121
pubmed: 23874387
Neurogenetics. 2006 May;7(2):67-80
pubmed: 16572319
Leuk Lymphoma. 2018 Nov;59(11):2628-2638
pubmed: 29616858
Oncogene. 2007 Jan 18;26(3):382-94
pubmed: 16878156
Clin Cancer Res. 2017 May 1;23(9):2232-2244
pubmed: 27923841
Leuk Lymphoma. 2011 Jan;52(1):108-21
pubmed: 21133714
Proc Natl Acad Sci U S A. 2016 Jul 5;113(27):E3911-20
pubmed: 27335461
Cancer Cell. 2002 Nov;2(5):401-13
pubmed: 12450795
J Immunol. 2005 Aug 15;175(4):2174-83
pubmed: 16081784
Int J Cancer. 2015 Mar 1;136(5):1033-42
pubmed: 25042405
Int J Clin Exp Med. 2015 Apr 15;8(4):5847-54
pubmed: 26131175
BMC Bioinformatics. 2006 Sep 29;7:422
pubmed: 17010189
Lancet Oncol. 2018 Apr;19(4):549-561
pubmed: 29475724
Biochem Biophys Res Commun. 2014 Feb 28;445(1):208-13
pubmed: 24508259
J Exp Clin Cancer Res. 2019 Aug 22;38(1):368
pubmed: 31439015
Biomark Res. 2018 Mar 13;6:11
pubmed: 29564133
Oncogene. 2013 Oct 17;32(42):5078-88
pubmed: 23208495
Genes Dev. 1999 Sep 1;13(17):2207-17
pubmed: 10485844
Life Sci. 1998;63(19):1701-13
pubmed: 9806226
J Biol Chem. 2006 Nov 3;281(44):33450-6
pubmed: 16950794
Nat Med. 1997 Aug;3(8):917-21
pubmed: 9256286
Front Oncol. 2019 Nov 20;9:1230
pubmed: 31824839
Biochem Pharmacol. 2020 Jun;176:113857
pubmed: 32061771
Leukemia. 2007 Apr;21(4):747-53
pubmed: 17287852
Oncogene. 2006 Feb 23;25(8):1125-42
pubmed: 16314846
Anat Rec (Hoboken). 2011 May;294(5):774-80
pubmed: 21433308